| Net income / (loss) | 29.91M |
| Loss from discontinued operations | |
| Depreciation and amortization | |
| Deferred income taxes | 230K |
| Stock-based compensation | 5.66M |
| Gain on sale of an asset held for sale | |
| Trade receivables | -60.39M |
| Inventories | -7.66M |
| Other current assets | |
| Accounts payable | -5.14M |
| Accrued liabilities | 12.89M |
| Current income taxes payable | -917K |
| Other non-current assets | -5.12M |
| Other non-current liabilities | |
| Net cash provided by / (used in) operating activities from continuing operations | -10.67M |
| Net cash (used in) operating activities from discontinued operations | |
| Net cash provided by / (used in) operating activities | |
| Capital expenditures | -3.85M |
| Trademarks | -296K |
| Proceeds from sale of an asset held for sale | |
| Net cash (used in) investing activities from continuing operations | -5.45M |
| Net cash (used in) investing activities from discontinued operations | |
| Net cash (used in) investing activities | |
| Proceeds from bank borrowings | 3M |
| Repayments of bank borrowings | -5M |
| Stock options exercised and other changes | |
| Distribution of noncontrolling interest earnings | |
| Dividends paid | -8.95M |
| Net cash (used in) / provided by financing activities from continuing operations | -16.96M |
| Net cash (used in) financing activities from discontinued operations | |
| Net cash (used in) / provided by financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | 4.65M |
| Net increase / (decrease) in cash and cash equivalents | -28.43M |
| Cash and cash equivalents at beginning of period | 228.19M |
| Cash and cash equivalents at end of period | 199.76M |